David R. Bauer
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/25898_drbauer.jpg?itok=Y1b0J_im)
Filters
Precigen $75 million follow-on offering
We advised Precigen on the SEC-registered offering
Deciphera Pharmaceuticals $135.1 million common stock offering
The common stock is listed on the Nasdaq Global Select Market
Sun Pharmaceutical acquisition of Concert Pharmaceuticals
We advised Sun Pharmaceutical on the transaction
OPAL Fuels warrant exchange offer
A total of 13,240,756 warrants were exchanged for stock
Terns Pharmaceuticals $86 million stock offering
The stock is listed on the Nasdaq Global Select Market
Illumina $1 billion notes offering
The investment-grade notes are due 2027
Prometheus Biosciences $500 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Trimble €1.88 billion Transporeon acquisition financing
We are advising the lead arranger and bookrunner on the acquisition financing
Lantheus Holdings $575 million convertible senior notes offering
The 2.625% convertible notes are due 2027
Biodesix $40 million follow-on offering
The shares are listed on the Nasdaq Global Market